Our results build upon previous findings in the WAGR patient population and suggest that a spectrum of clinical features and health issues can affect patients, prompting reclassification of this genetic disorder from WAGR syndrome to WAGR spectrum. This evidence concerns the gene WT1 and hereditary disease.